UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000010535
Receipt number R000012274
Scientific Title Multicenter Phase II study of rechallenge Cetuximab plus Irinotecan in heavily pretreated Wild type KRAS metastatic Colorectal cancer
Date of disclosure of the study information 2013/04/18
Last modified on 2023/04/25 17:30:14

No. Disposal Last modified on Item of update
1 Insert 2013/04/18 15:57:42
2 Update 2013/10/25 13:07:27 Email
Email
3 Update 2013/10/31 13:04:25 Email1
4 Update 2023/04/25 17:18:02 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Organization
Organization
Division name
Division name
Zip code
Address
Address
TEL
Email

Last name of contact person

Last name of contact person
Organization
Organization
Zip code
Address
Address
TEL
Email
Organization
Organization
Address
Address
TEL
Email
Name of primary person or sponsor
Institute
Institute
Department
Organization
Organization1
Address1
Tel1
Organization
Organization
Address
Address
Tel
Email
5 Update 2023/04/25 17:25:21 Recruitment status
Date of IRB
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
6 Update 2023/04/25 17:30:14 Number of participants that the trial has enrolled
Results
Results
Results date posted